ADA Scientific Sessions 2026 Abstract

Understanding the Implications of Incretin Receptor Desensitization

By Rashmita Basu, Jonathan Campbell, David M. D'Alessio

Experiments in animalsInterventions

The paper

Rashmita Basu, Jonathan Campbell, David M. D'Alessio

Durham

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2564-P

doi.org/10.2337/db26-2564-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Diabetes, Obesity & Metabolism4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes